Agathe Dubuisson
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Immune responses and vaccinations 2
-
- Tryptophan and brain disorders 2
- Co-authors
- Olivier Micheau (2 shared papers)Claudia Grajeda‐Iglesias (1 shared paper)François‐Xavier Danlos (1 shared paper)Eric Fourmaux (1 shared paper)Jean‐Pierre Galizzi (2 shared papers)Vincent Lombardi (2 shared papers)Luigi Cerbone (1 shared paper)Frank Madeo (1 shared paper)
In The Last Decade
Agathe Dubuisson
13 papers receiving 2.0k citations
Agathe Dubuisson's Hit Papers
Peers
Comparison fields: 5 of 96
- Immunology 645
- Infectious Diseases 552
- Biological Psychiatry 66
- Neurology 257
- Oncology 442
Countries citing papers authored by Agathe Dubuisson
This map shows the geographic impact of Agathe Dubuisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agathe Dubuisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agathe Dubuisson more than expected).
Fields of papers citing papers by Agathe Dubuisson
This network shows the impact of papers produced by Agathe Dubuisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agathe Dubuisson. The network helps show where Agathe Dubuisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Agathe Dubuisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 Hit paper breakdown → | 2020 | 620 |
| 2 | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer Hit paper breakdown → | 2022 | 536 |
| 3 | Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease Hit paper breakdown → | 2021 | 466 |
| 4 | 2021 | 130 | |
| 5 | 2020 | 101 | |
| 6 | 2017 | 72 | |
| 7 | 2022 | 63 | |
| 8 | 2021 | 31 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2024 | 9 | |
| 12 | 2019 | 7 | |
| 13 | 2025 | 2 |
About Agathe Dubuisson
Agathe Dubuisson is a scholar working on Immunology, Biological Psychiatry, Oncology, Neurology and Infectious Diseases, having authored 13 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers), Tryptophan and brain disorders (2 papers), COVID-19 Clinical Research Studies (2 papers), Cell death mechanisms and regulation (2 papers), Long-Term Effects of COVID-19 (2 papers), Immune responses and vaccinations (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (645 citations), Infectious Diseases (552 citations), Biological Psychiatry (66 citations), Neurology (257 citations) and Oncology (442 citations). Agathe Dubuisson has collaborated with scholars based in France, Italy and Australia. Frequent co-authors include Olivier Micheau, Claudia Grajeda‐Iglesias, François‐Xavier Danlos, Eric Fourmaux, Jean‐Pierre Galizzi, Vincent Lombardi, Luigi Cerbone, Frank Madeo, laurence ZITVOGEL and Hélène Darville. Their work appears in journals such as Cell Death and Disease, Frontiers in Immunology, Cell Death and Differentiation, Aging and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.